Mark R. Ziebell
2020
Compensation breakdown
| Non-Equity Incentive Plan | $33,923 |
|---|---|
| Option Awards | $377,782 |
| Salary | $372,358 |
| Stock Awards | $255,244 |
| Other | $46,317 |
| Total | $1,085,624 |
Ziebell received $377.8K in option awards, accounting for 35% of the total pay in 2020.
Ziebell also received $33.9K in non-equity incentive plan, $372.4K in salary, $255.2K in stock awards and $46.3K in other compensation.
Rankings
In 2020, Mark R. Ziebell's compensation ranked 8,295th out of 13,090 executives tracked by ExecPay. In other words, Ziebell earned more than 36.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,295 out of 13,090 | 37th |
Division Manufacturing | 3,520 out of 5,620 | 37th |
Major group Chemicals And Allied Products | 1,423 out of 2,253 | 37th |
Industry group Drugs | 1,239 out of 1,953 | 37th |
Industry Pharmaceutical Preparations | 917 out of 1,458 | 37th |
Pay ratio
| Mark R. Ziebell's Pay | $1,085,624 |
|---|---|
| Median Employee's Pay | $83,115 |
| Pay Ratio | 13to 1 |
In 2020, the annual total compensation of Mark R. Ziebell was $1,085,624.
The annual total compensation of the median employee at Peregrine Pharmaceuticals was $83,115.
The ratio of Mark R. Ziebell's pay to the pay of median employee was therefore 13 to one.
Ziebell's colleagues
We found three more compensation records of executives who worked with Mark R. Ziebell at Peregrine Pharmaceuticals in 2020.
News
August 28, 2023
August 29, 2022
August 27, 2021
August 27, 2020
August 21, 2019
August 17, 2018